Literature DB >> 10215226

Human complement regulatory proteins protect swine lungs from xenogeneic injury.

M Yeatman1, C W Daggett, C L Lau, G W Byrne, J S Logan, J L Platt, R D Davis.   

Abstract

BACKGROUND: Pulmonary xenotransplantation is not possible because of hyperacute lung injury, the pathogenesis of which is unknown. This study evaluates complement-dependent pathways of pulmonary injury during heterologous perfusion of swine lungs.
METHODS: Lungs from unmodified swine and swine expressing human decay-accelerating factor and human CD59 (hDAF/hCD59 swine) were perfused with either human plasma or baboon blood. Pulmonary vascular resistance and static pulmonary compliance were measured serially, and swine lung tissue were examined by light microscopy. Complement activation was assessed by serial measurements of baboon plasma C3a-desArg concentrations.
RESULTS: Perfusion of unmodified swine lungs with human plasma and baboon blood resulted in hyperacute lung injury within minutes of perfusion. However, function was preserved in swine lungs expressing human decay-accelerating factor and human CD59. In both study groups, xenogeneic perfusion with baboon blood resulted in at least a sevenfold increase in plasma C3a-desArg levels suggesting transient activation of complement.
CONCLUSIONS: Lungs from swine expressing human decay-accelerating factor and human CD59 were resistant to injury during perfusion with human plasma and baboon blood, indicating that complement mediated some of the features of xenogeneic acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215226     DOI: 10.1016/s0003-4975(99)00049-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Immune complex formation after xenotransplantation : evidence of type III as well as type II immune reactions provide clues to pathophysiology.

Authors:  Z E Holzknecht; S Coombes; B A Blocher; T B Plummer; M Bustos; C L Lau; R D Davis; J L Platt
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 2.  Clinical lung xenotransplantation--what donor genetic modifications may be necessary?

Authors:  David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

3.  Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation.

Authors:  Daniel M Takefman; Gregory T Spear; Mohammed Saifuddin; Carolyn A Wilson
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor.

Authors:  Sergey S Seregin; Zachary C Hartman; Daniel M Appledorn; Sarah Godbehere; Haixiang Jiang; Michael M Frank; Andrea Amalfitano
Journal:  J Innate Immun       Date:  2010-02-11       Impact factor: 7.349

5.  64-channel multi-detector row CT angiographic evaluation of the micropigs for potential living donor lung transplantation.

Authors:  Woong Yoon; Jung Min Ryu; Min Young Lee; Yong Ju Moon; Sang Hun Lee; Jae Hong Park; Seung Pil Yun; Min Woo Jang; Sung Su Park; Ho Jae Han
Journal:  J Vet Sci       Date:  2010-09       Impact factor: 1.672

Review 6.  Complement-mediated microvascular injury leads to chronic rejection.

Authors:  Mohammad A Khan; Mark R Nicolls
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.